Whitehawk Therapeutics, Inc. (WHWK)
4.30
+0.08
(+1.90%)
USD |
NASDAQ |
May 21, 16:00
4.30
0.00 (0.00%)
After-Hours: 19:59
Whitehawk Therapeutics Research and Development Expense (TTM) : 99.41M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | 17.95M |
| Replimune Group, Inc. | 222.70M |
| Lantern Pharma, Inc. | 9.975M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| Alnylam Pharmaceuticals, Inc. | 1.420B |